Company Profile  0-9   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z 
  Search DR Directory
Symbol Lookup  

Program Information Company Profile Company Market News Interactive Charting Company Financials Company Calendar of Events DR Program News/Events Company Books Close / Open Notices Company Capital Raisings Company Certification Papers Company Corporate Actions Company Dividends / GDN Interest Payments Company DSF Notices Shareholder Information Estimated Fee Calculator

Company Market News

Takeda Pharmaceutical Co. Ltd. (NYSE: TAK)
8:00 PM UTC, 04/25/25
Last: $15.03 Change: -0.08 %Change: -0.53% Volume: 2,188,250
News Headlines for TAKEDA PHARMACEUTICAL CO. LTD.
04/03/2025 10:49am Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading
03/27/2025 9:39am Mirum Pharmaceuticals Says Livmarli Approved in Japan for Pruritus
03/03/2025 9:00am Protagonist, Takeda Say Phase 3 Study of Rusfertide Meets Endpoints in Polycythemia Vera
02/24/2025 4:26am Takeda Secures EMA Approval for Additional Injection Option for Hereditary Angioedema Drug
01/30/2025 5:37am Takeda Pharmaceutical Names Julie Kim Chief Executive
01/30/2025 5:37am Takeda Pharmaceutical Names Julie Kim Chief Executive
01/30/2025 5:03am Takeda Pharmaceutical Fiscal Q3 Core Earnings Decline, Revenue Rises
01/30/2025 5:03am Takeda Pharmaceutical Fiscal Q3 Core Earnings Decline, Revenue Rises
01/29/2025 9:03am Takeda Pharmaceutical Says Hema-Quebec to Cover HyQvia for Immunodeficiency Treatment
01/29/2025 9:03am Takeda Pharmaceutical Says Hema-Quebec to Cover HyQvia for Immunodeficiency Treatment
01/27/2025 5:28pm Neurocrine Amends Collaboration with Takeda on Osavampator
01/27/2025 5:28pm Neurocrine Amends Collaboration with Takeda on Osavampator
01/21/2025 9:15am Keros to Receive $200 Million From Takeda In Connection to Elritercept License Deal
01/21/2025 9:15am Keros to Receive $200 Million From Takeda In Connection to Elritercept License Deal
01/21/2025 4:40am Takeda Canada Says Health Canada Granted Market Authorization for Fruzaqla
01/21/2025 4:40am Takeda Canada Says Health Canada Granted Market Authorization for Fruzaqla
12/27/2024 9:05am Sector Update: Health Care Stocks Mixed Pre-Bell Friday
12/27/2024 9:05am Sector Update: Health Care Stocks Mixed Pre-Bell Friday
12/27/2024 3:39am Takeda Pharmaceutical"s Hyqvia Approved in Japan for Patients With Immune Disorders
12/27/2024 3:39am Takeda Pharmaceutical"s Hyqvia Approved in Japan for Patients With Immune Disorders
12/13/2024 4:59am Hutchmed to Receive $10 Million Milestone Payment Through Takeda
12/13/2024 4:59am Hutchmed to Receive $10 Million Milestone Payment Through Takeda
12/03/2024 7:52am Keros Therapeutics Enters Global Development, License Deal with Takeda Pharmaceutical for Elritercept
12/03/2024 7:52am Keros Therapeutics Enters Global Development, License Deal with Takeda Pharmaceutical for Elritercept
11/22/2024 4:01am Hutchmed to Receive Milestone Payment for Takeda"s Fruzaqla Launch in Japan



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.